LKFT
Lakefront Biotherapeutics
$31.69
+$0.03 (+0.11%)Oct 26, 2026
Key metrics
The numbers that frame LKFT today
- Market cap
- $2.09B
- Gross margin
- 97.9%
- EV / Sales
- 1.7
- ROIC
- 15%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $25.68
- 52wk High
- $36.24
Growth
Revenue and earnings trend for LKFT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LKFT
Is Lakefront Biotherapeutics a good buy?
Yes. Lakefront Biotherapeutics has excellent quality and mixed momentum. Taken together, the setup leans positive. Growth looks excellent, which supports the long-term business case. We think Lakefront Biotherapeutics is selling at a fair price.
What is the market capitalization of LKFT?
Lakefront Biotherapeutics's market capitalization is $2.09B.
What is the 52-week high for LKFT stock?
The 52-week high for Lakefront Biotherapeutics is $36.24. The current close of $31.69 is 12.6% below that high.
What is the 52-week low for LKFT stock?
The 52-week low for Lakefront Biotherapeutics is $25.68. The current close of $31.69 is 23.4% above that low.
Does LKFT stock pay dividends?
Lakefront Biotherapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LKFT?
Lakefront Biotherapeutics's Debt / Equity ratio is 0.